Clinical trials
Recruiting Phase 3 Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 9 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurocrine Biosciences | 4 |
| Bristol-Myers Squibb | 2 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2 |
| LB Pharmaceuticals Inc. | 2 |
| Alkermes, Inc. | 1 |
| Central South University | 1 |
| Dr. Inge Winter | 1 |
| Gedeon Richter Plc. | 1 |
| Institute of Mental Health, Singapore | 1 |
| Intra-Cellular Therapies, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 22 |
| Bipolar Disorder | 2 |
| Mental Disorders | 2 |
| Psychotic Disorders | 2 |
| Autism Spectrum Disorder | 1 |
| Autistic Disorder | 1 |
| Dyslipidemias | 1 |
| Lethargy | 1 |
| Major Depressive Disorder | 1 |
| Schizophrenia, Treatment-Resistant | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.